Marwan Sabbagh - 14 Jun 2024 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role
Director
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
Issuer symbol
CRVO
Transactions as of
14 Jun 2024
Net transactions value
$0
Form type
4
Filing time
14 Jun 2024, 18:20:01 UTC
Previous filing
15 Sep 2023
Next filing
25 Jun 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVO Stock Option (Right to Buy) Award $0 +5,750 $0.000000 5,750 14 Jun 2024 Common Stock 5,750 $19.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date.